Table 1.

Selected demographic, clinical, and treatment characteristics and clinical outcome in training and testing set cohorts.

	Training set	Testing set
Age, mean (range)	60.91 (39–88)	57.35 (23–78)
Females, n (%)	28 (39.4)	33 (38.8)
Reached within routine working hours, n (%)	36 (50.7)	47 (55.29)
Hypertension, n(%)	40 (56.34)	51 (60)
Diabetes, n (%)	26 (36.62)	35 (41.17)
Smoking, n (%)	16 (22.53)	10 (11.76)
Coronary artery disease, n (%)	15 (21.1)	16 (18.8)
Valvular heart disease, n (%)	11 (15.4)	21 (24.7)
Dyslipidemia, n (%)	15 (21.1)	22 (25.88)
Past Stroke, n (%)	9 (12.6)	16 (18.8)
Antiplatelet medications, n (%)	18 (25.35)	25 (29.41)
Right Hemisphere, n (%)	35 (49.29)	38 (44.70)
NIHSS at admission, median (IQR)	16 (12–20)	16 (11–21)
mRS at admission, median (IQR)	4 (4–4)	4 (4–5)
Baseline CT ASPECTS, median (IQR)	7 (6–8)	6 (5–7)
Hyperdense middle cerebral artery sign, n (%)	37 (52.11)	43 (50.58)
Occluded vessel
ICA and beyond, n (%)	12 (16.90)	23 (27.05)
M1, MCA and beyond, n (%)	58 (81.69)	59 (69.41)
Involvement of anterior cerebral artery, n (%)	9 (12.6)	13 (15.29)
Clot burden score, median (IQR)	6 (5–6)	6 (4–6)
Thrombus length, median (IQR)	10 (14–7)	11 (14–8)
Modified tan score, n (%)	38 (53.52)	44 (51.76)
Bridging thrombolysis, n (%)	27 (38.02)	26 (30.58)
TICI score
0, n (%)	1 (1.40)	7 (8.23)
1, n (%)	3 (4.22)	4 (4.7)
2a, n (%)	7 (9.85)	13 (15.29)
2b, n (%)	24 (33.8)	28 (32.94)
2c+3, n (%)	36 (50.7)	32 (37.64)
Symptomatic intracerebral bleed, n (%)	4 (5.63)	6 (7.05)
24 hour CT ASPECTS score, median (IQR)	6 (5–7)	6 (4–7)
mRS at Discharge, median (IQR)	3 (2-4)	4 (2-4)
mRS at 3 months, median (IQR)	2 (1-3)	3 (1-4)
Time from stroke onset	108	110
to recanalisation, median (range in minutes)	(45–250)	(30–345)